Abstract
Objectives: The aim of this review was to examine the prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population. Methods: A systematic search of studies related to chronic heart failure (CHF) in the diabetic population was performed using medical databases. Results: 1) The prevalence of CHF in the diabetic population was approximately 10-23% in the large previously studied cohort. This was about three times higher than in nondiabetic control groups. 2) The incidence of CHF in diabetes varied greatly. It was influenced by the time of follow-up, the mean age of patients, the state of metabolic control and the complications of diabetes. The incidence of CHF in patients with diabetes was approximately two-fold greater than in the non-diabetic population. 3) The main risk factors of CHF in the type 2 diabetic population were age, hemoglobin A1c (HbA1c), coronary heart disease, hypertension, microalbuminuria and obesity. Conclusions: The prevalence and incidence of CHF were found to be high in the diabetic population, and the risk factors of CHF were somewhat different from those in the general population.
Keywords: Prevalence, Incidence, Risk factors, Chronic heart failure, Diabetes, Systematic review
Current Diabetes Reviews
Title: Prevalence, Incidence and Risk Factors of Chronic Heart Failure in the Type 2 Diabetic Population: Systematic Review
Volume: 5 Issue: 3
Author(s): Linuo Zhou, Wei Deng, Lixue Zhou, Ping Fang, Daikun He, Weiwei Zhang, Kui Liu and Renming Hu
Affiliation:
Keywords: Prevalence, Incidence, Risk factors, Chronic heart failure, Diabetes, Systematic review
Abstract: Objectives: The aim of this review was to examine the prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population. Methods: A systematic search of studies related to chronic heart failure (CHF) in the diabetic population was performed using medical databases. Results: 1) The prevalence of CHF in the diabetic population was approximately 10-23% in the large previously studied cohort. This was about three times higher than in nondiabetic control groups. 2) The incidence of CHF in diabetes varied greatly. It was influenced by the time of follow-up, the mean age of patients, the state of metabolic control and the complications of diabetes. The incidence of CHF in patients with diabetes was approximately two-fold greater than in the non-diabetic population. 3) The main risk factors of CHF in the type 2 diabetic population were age, hemoglobin A1c (HbA1c), coronary heart disease, hypertension, microalbuminuria and obesity. Conclusions: The prevalence and incidence of CHF were found to be high in the diabetic population, and the risk factors of CHF were somewhat different from those in the general population.
Export Options
About this article
Cite this article as:
Zhou Linuo, Deng Wei, Zhou Lixue, Fang Ping, He Daikun, Zhang Weiwei, Liu Kui and Hu Renming, Prevalence, Incidence and Risk Factors of Chronic Heart Failure in the Type 2 Diabetic Population: Systematic Review, Current Diabetes Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157339909788920938
DOI https://dx.doi.org/10.2174/157339909788920938 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Oral Anticoagulants: Recommendations for Patient Evaluation, Treatment Initiation, Follow-up and Perioperative Management
Cardiovascular & Hematological Disorders-Drug Targets Apolipoprotein B Antisense Inhibition -Update on Mipomersen
Current Pharmaceutical Design Withdrawal Notice: The Recent Advancement in the Field of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) for Aiming Breast Cancer
Current Drug Metabolism High Blood Pressure and the Risk of Stroke
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Metabolism-based Drug-drug Interactions in Patients with Chronic Respiratory Diseases: A Review Focusing on Drugs Affecting the Respiratory System
Current Drug Metabolism Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry New Foods, New Consumers: Innovation in Food Product Development
Current Nutrition & Food Science Pharmacogenomics of Cardiovascular Complications in Diabetes and Obesity
Recent Patents on Biotechnology Characterization of Single Nucleotide Polymorphisms of Cytochrome P450 in an Australian Deceased Sample
Current Drug Metabolism MTHFR Gene Polymorphism and Diabetic Retinopathy
Current Diabetes Reviews Endothelial Dysfunction in Hyperglycemia as a Trigger of Atherosclerosis
Current Diabetes Reviews Oxidative Stress in Essential Hypertension
Current Pharmaceutical Design Immunosuppression in Sepsis
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Stem Cell Research & Therapy Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
Current Cardiology Reviews Modulation of Retinal Arteriolar Central Reflection by APOE Genotype
Current Alzheimer Research Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
Anti-Cancer Agents in Medicinal Chemistry Biochemical Markers of Cardiovascular Damage from Tobacco Smoke
Current Pharmaceutical Design Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
Current Medicinal Chemistry Pharmacotherapy of Abdominal Aortic Aneurysms
Current Vascular Pharmacology